A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC (ARMOR3-SV)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02438007 |
|
Recruitment Status :
Terminated
First Posted : May 8, 2015
Last Update Posted : September 28, 2017
|
Sponsor:
Novus Therapeutics, Inc
Information provided by (Responsible Party):
Novus Therapeutics, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | July 2016 |
| Actual Study Completion Date : | November 2016 |
| Certification/Extension First Submitted : | September 21, 2017 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):